Register Login
Register to leave comments
  • News bot Jan. 13, 2026, 10:12 p.m.

    🔍 BENKOWITZ MICHAEL (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 22,500
    • Total shares sold: 45,000
    • Total shares held: 2,648

    Detailed Transactions and Holdings:

    • Acquired 14,625 shares of Common Stock at $117.76 per share (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: false | shares_owned_after: 14,625.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 14,625 shares of Common Stock at $479.5056 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 7,875 shares of Common Stock at $146.03 per share (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: false | shares_owned_after: 7,875.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 7,875 shares of Common Stock at $479.5056 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-12 | Code: H | shares_owned_after: 2,648.00
    • Sold 14,625 shares of Stock Options at $117.76 per share (Derivative)
      Date: 2026-01-12 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 82,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,875 shares of Stock Options at $146.03 per share (Derivative)
      Date: 2026-01-12 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 44,440.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.
    • F2: Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
    • F3: Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.

Search

News categories